Lista de obras -

A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation.

artículo científico publicado en 2012

Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.

artículo científico publicado en 2016

Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.

artículo científico publicado en 2012

Cardiac Recovery During Long-Term Left Ventricular Assist Device Support.

artículo científico publicado en 2016

Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.

artículo científico publicado en 2009

Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation

artículo científico publicado en 2014

Early screening for antibody-mediated rejection in heart transplant recipients.

artículo científico publicado en 2007

Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation.

artículo científico publicado en 2017

ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.

artículo científico publicado en 2015

Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.

artículo científico publicado en 2016

Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.

artículo científico publicado en 2006

Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.

artículo científico publicado en 2012

Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.

artículo científico publicado en 2013

Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations

artículo científico publicado en 2015

Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.

artículo científico publicado en 2014

Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

artículo científico publicado en 2013

Reply: left ventricular assist devices in chronic heart failure: more questions than answers?

artículo científico publicado en 2013

Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies.

artículo científico publicado en 2005

Lista de obras de

A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation.

Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.

Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.

Cardiac Recovery During Long-Term Left Ventricular Assist Device Support.

Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.

Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation

Early screening for antibody-mediated rejection in heart transplant recipients.

Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation.

ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.

Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.

Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.

Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.

Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.

Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations

Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.

Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

Reply: left ventricular assist devices in chronic heart failure: more questions than answers?

Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies.